Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.

T. Yamauchi, T. Ogura, T. Oishi, K. Harada, M. Hashimoto, Yukari Mimura, N. Asano, Z. Ota, J. Kageyama

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

To elucidate the effect of the arginine vasopressin (AVP) system in vivo, especially V1 and V2 activity, on blood pressure, we measured the acute changes in blood pressure and heart rate after AVP, OPC-21,268 (a V1 receptor antagonist), and OPC-31,260 (a V2 receptor antagonist) were injected intravenously in anesthetized spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats at the age of 15 weeks. Compared with the control period, single injection of AVP 5 ng/kg significantly increased systolic blood pressure in WKY rats without a concomitant increase in heart rate, but there was no significant increase in blood pressure in SHR. In contrast, single injection of either OPC-21,268 3 mg/kg or OPC-31,260 3 mg/kg did not affect blood pressure or heart rate in either SHR or WKY rats. Injection of AVP after the administration of OPC-31,260 induced a greater increase in blood pressure in SHR than in WKY rats, whereas injection of AVP after the administration of OPC-21,268 did not induce any clear increase in blood pressure in SHR or WKY rats. These results suggest that SHR have enhanced pressor activity mediated by V1 receptors and that this increase may be due to an increase in their number. In conclusion, enhancement of V1 activity may contribute to the development of high blood pressure in SHR.

Original languageEnglish
Pages (from-to)53-59
Number of pages7
JournalActa Medica Okayama
Volume49
Issue number1
Publication statusPublished - Feb 1995

Fingerprint

Vasopressin Receptors
Inbred SHR Rats
Vasopressins
Rats
Blood pressure
Inbred WKY Rats
Arginine Vasopressin
Blood Pressure
Injections
Heart Rate
Hypertension

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Yamauchi, T., Ogura, T., Oishi, T., Harada, K., Hashimoto, M., Mimura, Y., ... Kageyama, J. (1995). Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors. Acta Medica Okayama, 49(1), 53-59.

Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors. / Yamauchi, T.; Ogura, T.; Oishi, T.; Harada, K.; Hashimoto, M.; Mimura, Yukari; Asano, N.; Ota, Z.; Kageyama, J.

In: Acta Medica Okayama, Vol. 49, No. 1, 02.1995, p. 53-59.

Research output: Contribution to journalArticle

Yamauchi, T, Ogura, T, Oishi, T, Harada, K, Hashimoto, M, Mimura, Y, Asano, N, Ota, Z & Kageyama, J 1995, 'Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.', Acta Medica Okayama, vol. 49, no. 1, pp. 53-59.
Yamauchi, T. ; Ogura, T. ; Oishi, T. ; Harada, K. ; Hashimoto, M. ; Mimura, Yukari ; Asano, N. ; Ota, Z. ; Kageyama, J. / Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors. In: Acta Medica Okayama. 1995 ; Vol. 49, No. 1. pp. 53-59.
@article{37e369d7f25245209f8b41f6a09e1a53,
title = "Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.",
abstract = "To elucidate the effect of the arginine vasopressin (AVP) system in vivo, especially V1 and V2 activity, on blood pressure, we measured the acute changes in blood pressure and heart rate after AVP, OPC-21,268 (a V1 receptor antagonist), and OPC-31,260 (a V2 receptor antagonist) were injected intravenously in anesthetized spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats at the age of 15 weeks. Compared with the control period, single injection of AVP 5 ng/kg significantly increased systolic blood pressure in WKY rats without a concomitant increase in heart rate, but there was no significant increase in blood pressure in SHR. In contrast, single injection of either OPC-21,268 3 mg/kg or OPC-31,260 3 mg/kg did not affect blood pressure or heart rate in either SHR or WKY rats. Injection of AVP after the administration of OPC-31,260 induced a greater increase in blood pressure in SHR than in WKY rats, whereas injection of AVP after the administration of OPC-21,268 did not induce any clear increase in blood pressure in SHR or WKY rats. These results suggest that SHR have enhanced pressor activity mediated by V1 receptors and that this increase may be due to an increase in their number. In conclusion, enhancement of V1 activity may contribute to the development of high blood pressure in SHR.",
author = "T. Yamauchi and T. Ogura and T. Oishi and K. Harada and M. Hashimoto and Yukari Mimura and N. Asano and Z. Ota and J. Kageyama",
year = "1995",
month = "2",
language = "English",
volume = "49",
pages = "53--59",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "1",

}

TY - JOUR

T1 - Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.

AU - Yamauchi, T.

AU - Ogura, T.

AU - Oishi, T.

AU - Harada, K.

AU - Hashimoto, M.

AU - Mimura, Yukari

AU - Asano, N.

AU - Ota, Z.

AU - Kageyama, J.

PY - 1995/2

Y1 - 1995/2

N2 - To elucidate the effect of the arginine vasopressin (AVP) system in vivo, especially V1 and V2 activity, on blood pressure, we measured the acute changes in blood pressure and heart rate after AVP, OPC-21,268 (a V1 receptor antagonist), and OPC-31,260 (a V2 receptor antagonist) were injected intravenously in anesthetized spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats at the age of 15 weeks. Compared with the control period, single injection of AVP 5 ng/kg significantly increased systolic blood pressure in WKY rats without a concomitant increase in heart rate, but there was no significant increase in blood pressure in SHR. In contrast, single injection of either OPC-21,268 3 mg/kg or OPC-31,260 3 mg/kg did not affect blood pressure or heart rate in either SHR or WKY rats. Injection of AVP after the administration of OPC-31,260 induced a greater increase in blood pressure in SHR than in WKY rats, whereas injection of AVP after the administration of OPC-21,268 did not induce any clear increase in blood pressure in SHR or WKY rats. These results suggest that SHR have enhanced pressor activity mediated by V1 receptors and that this increase may be due to an increase in their number. In conclusion, enhancement of V1 activity may contribute to the development of high blood pressure in SHR.

AB - To elucidate the effect of the arginine vasopressin (AVP) system in vivo, especially V1 and V2 activity, on blood pressure, we measured the acute changes in blood pressure and heart rate after AVP, OPC-21,268 (a V1 receptor antagonist), and OPC-31,260 (a V2 receptor antagonist) were injected intravenously in anesthetized spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats at the age of 15 weeks. Compared with the control period, single injection of AVP 5 ng/kg significantly increased systolic blood pressure in WKY rats without a concomitant increase in heart rate, but there was no significant increase in blood pressure in SHR. In contrast, single injection of either OPC-21,268 3 mg/kg or OPC-31,260 3 mg/kg did not affect blood pressure or heart rate in either SHR or WKY rats. Injection of AVP after the administration of OPC-31,260 induced a greater increase in blood pressure in SHR than in WKY rats, whereas injection of AVP after the administration of OPC-21,268 did not induce any clear increase in blood pressure in SHR or WKY rats. These results suggest that SHR have enhanced pressor activity mediated by V1 receptors and that this increase may be due to an increase in their number. In conclusion, enhancement of V1 activity may contribute to the development of high blood pressure in SHR.

UR - http://www.scopus.com/inward/record.url?scp=0029249699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029249699&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 53

EP - 59

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 1

ER -